Applications were made just prior to Bill Gates 3
Post# of 154852
(Total Views: 1918)
Posted On: 01/24/2025 11:27:17 PM
Applications were made just prior to Bill Gates 3 hour dinner with Trump.
Love the excerpts:
*To effectively slow the epidemic, approaches are needed to both suppress viral replication long-term and halt new infections
*Therefore, the development of new user-friendly HIV suppression and PrEP regimens, particularly with simplified dosing regimens that lack unwanted negative side effects, is an urgent global health need.
*0008] To this end, the present disclosure provides recombinant adenovirus-associated viral vectors for the delivery of CCR5 binding agents with increased effector function and circulation half-life that are useful for treating and preventing HIV and methods of using the same.
*Also provided are methods for the treatment and prevention of HIV by administering to the patient, an effective amount said rAAV vectors.
*CCR5 Binding Agents
[0065] The present disclosure provides for use of a CCR5 binding agent, e.g., leronlimab,
Cytodyn has taken steps to patent the cure.
Outstanding
Love the excerpts:
*To effectively slow the epidemic, approaches are needed to both suppress viral replication long-term and halt new infections
*Therefore, the development of new user-friendly HIV suppression and PrEP regimens, particularly with simplified dosing regimens that lack unwanted negative side effects, is an urgent global health need.
*0008] To this end, the present disclosure provides recombinant adenovirus-associated viral vectors for the delivery of CCR5 binding agents with increased effector function and circulation half-life that are useful for treating and preventing HIV and methods of using the same.
*Also provided are methods for the treatment and prevention of HIV by administering to the patient, an effective amount said rAAV vectors.
*CCR5 Binding Agents
[0065] The present disclosure provides for use of a CCR5 binding agent, e.g., leronlimab,
Cytodyn has taken steps to patent the cure.
Outstanding
(8)
(0)